TrialClinical trialPHN-02982026-10-05 19:00 CT
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
Source · ClinicalTrials.gov: peptide AND aging
TLDR
A ClinicalTrials.gov listing reports that a study of tirzepatide in post-menopausal women with obesity is recruiting. The study aims to assess effects on menopausal vasomotor symptoms and measures of biological aging.
01—Key points
- 01The trial is listed as recruiting.
- 02Participants are post-menopausal women with obesity.
- 03The excerpt provides the study purpose but no results.
Why it matters Editorial
The study examines tirzepatide's potential effects on menopausal symptoms and biological aging, but the excerpt provides no evidence of benefit.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
02—Related news
Trial
PHN-0282
2026-10-29 19:00 CT
Tirzepatide and Organ-specific Biological Aging
ClinicalTrials.gov: peptide AND aging
Study
PHN-0004
2026-10-27 11:00 CT